- Home
- Clinical Trials
Norovirus Study Sydney DH 14
Norovirus Study
Darlinghurst Sydney
Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming Norovirus studies here.
Description
What to expect
Study details
Ages
18+ years of age
Duration
Approximately 2 years, you will have at least 6 clinic visits and 6 telephone calls
Compensation
Participants will be reimbursed up to $1,618
Eligibility Criteria
To join this study, here’s what we’re looking for:
- Are 18 years or older
- Are in good health or have well-controlled medical conditions
- Are not pregnant at the time of trial start or become pregnant in the first 3 months of the trial.
Locations
Description
Norovirus, commonly referred to as a stomach bug, food poisoning or a gastro virus, is highly contagious and can cause symptoms such as sudden nausea, vomiting, stomach pain and diarrhoea that usually last 1 to 3 days.
Norovirus can affect anyone, but young children, older adults and those with chronic health conditions are at a higher risk of severe symptoms that can lead to dehydration and may require hospitalisation.
Norovirus spreads rapidly in places where people gather such as day care centres, schools, retirement communities, hospitals, aeroplanes and restaurants. It can be passed on unknowingly and can cause major disruption to daily life and the ability to work.
What to expect
Momentum Clinical Research is conducting a research study investigating an investigational vaccine that aims to prevent Norovirus disease. The study will evaluate the safety, immune response, and effectiveness of the investigational mRNA or messenger RNA vaccine.
What is an mRNA vaccine and how does it work?
A messenger RNA (mRNA) vaccine produces three different types of virus - like particles (VLPs). These particles train your immune system to recognise the virus and help protect you from the symptoms it may cause if you are exposed to it in the future.
The aim of this study is for the investigational mRNA vaccine to train the immune system cells to “remember” the proteins and help the body quickly respond to the virus if exposed in the future.
You cannot get norovirus from the investigational vaccine in this clinical trial.
This is a placebo-controlled study, which means that some participants will receive a placebo and some participants will receive the active investigational vaccine.
Volunteers like you are essential to advancing medical research. Register your interest in joining this study now.